14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus – Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

Breast care

Nicolai Maass¹  Wolfgang Janni¹  Nadia Harbeck¹  Ingo Diel¹  Peter A. Fasching¹  Gunter von Minckwitz¹  Christoph Thomssen¹  Matthias W. Beckmann¹  Thomas Decker¹  Christian Jackisch¹  Volker Möbus¹  Heike Scheithauer¹  Jens-Uwe Blohmer¹  Serban-Dan Costa¹  Jens Huober¹  Andreas Schneeweiss¹  Hans-Heinrich Kreipe¹  Sibylle Loibl¹  Michael Untch¹  Tanja Fehm¹  Norbert Marschner¹  Bernd Gerber¹  Hans-Joachim Lück¹  Cornelia Liedtke¹  Anton Scharl¹ 

[1] aKlinik für Gynäkologie und Geburtshilfe, Sana-Klinikum Offenbach, Germany

关键词: St. Gallen Consensus 2015;    Systemic therapy;    Local therapy;    Sentinel node biopsy;    Endocrine therapy;    Targeted substances;    Multigene assay;   

DOI  :  10.1159/000433590

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

The key topics of this year's 14th St. Gallen Consensus Conference on the diagnosis and therapy of primary breast cancer were again questions about breast surgery and axillary surgery, radio-oncology and systemic therapy options in consideration of tumor biology, and the clinical application of multigene assays. This year, the consensus conference took place in Vienna. From a German perspective, it makes sense to substantiate the results of the vote of the international panel representing 19 countries in light of the updated national therapy recommendations of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie). Therefore, 14 German breast cancer experts, 3 of whom are members of the International St. Gallen Panel, have commented on the voting results of the St. Gallen Consensus Conference 2015 in relation to clinical routine in Germany.

【 授权许可】

Unknown